Moderna Seeks FDA Approval for Enhanced Covid Vaccine Targeting Fall Season

A vial and a medical syringe seen displayed in front of the U.S. Food and Drug Administration and Moderna biotechnology company’s logos. Pavlo Gonchar | LightRocket | Getty Images Moderna has officially submitted its updated Covid vaccine for FDA approval. The biotech company is targeting the omicron subvariant XBB.1.5, which is currently the dominant strain …

Read more

CDC Panel Advises Adults Over 60 to Choose Pfizer and GSK Vaccines

A healthcare professional in Los Angeles prepares a flu vaccine shot for a local resident. Xinhua News Agency | Getty Images A committee advising the Centers for Disease Control and Prevention (CDC) has recommended that adults aged 60 and above consult their doctors and receive a single dose of RSV vaccines from Pfizer and GSK. …

Read more

Decline in Efficacy of Pfizer Adult RSV Vaccine Observed After 18 Months

A Potential Breakthrough: Pfizer’s Ongoing Research on Respiratory Syncytial Virus Vaccines Image Source: Hailshadow | Istock | Getty Images Pfizer reported a slight decrease in the efficacy of their respiratory syncytial virus (RSV) vaccine for adults over the age of 60 after 18 months, based on the results of a recent clinical trial. The trial, …

Read more

Long-term Protection Offered by GSK’s RSV Vaccine for Older Adults

Exciting Advances in Respiratory Syncytial Virus Vaccine Research Image Source: Hailshadow | Istock | Getty Images – GlaxoSmithKline announced today that their respiratory syncytial virus (RSV) vaccine for adults aged 60 and older has proven effective over two RSV seasons. According to recent data from a phase three clinical trial, a single dose of the …

Read more

Jim Cramer Recognizes Troubles in These 3 Stocks but Remains Resilient

If someone were to inform me that esteemed companies like Estee Lauder (EL) or Danaher (DHR) have not only missed their quarterly targets once, but twice, I would have suggested they seek a mental evaluation. These companies are known for consistently surpassing expectations, which is why it is challenging to accurately assess their value at …

Read more

Pfizer, Moderna, and Novavax prep for autumn rollout

In a noteworthy development, the U.S. Food and Drug Administration (FDA) has selected Pfizer, Moderna, and Novavax as the manufacturers for the next round of COVID-19 booster shots. This decision sets the stage for a competitive race among the vaccine makers as they strive to deliver their new jabs by fall. The FDA has advised …

Read more

Dice Therapeutics to be acquired by Eli Lilly in $2.4 billion deal

David Ricks, CEO, Eli Lilly Scott Mlyn | CNBC Eli Lilly announced on Tuesday that it has entered into a strategic deal valued at $2.4 billion to acquire Dice Therapeutics . This strategic move will strengthen Eli Lilly’s treatment portfolio for immune-related diseases. The deal will involve Eli Lilly acquiring Dice Therapeutics at a price …

Read more